Viewing Study NCT01464359


Ignite Creation Date: 2025-12-24 @ 3:04 PM
Ignite Modification Date: 2026-06-07 @ 6:11 PM
Study NCT ID: NCT01464359
Status: TERMINATED
Last Update Posted: 2017-12-28
First Post: 2011-11-01
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: T-Cell Depleted Double UCB for Refractory AML
Sponsor: Masonic Cancer Center, University of Minnesota
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Acute Myelogenous Leukemia View
None Refractory Acute Myelogenous Leukemia View
Keywords:

Keywords

Keyword Brief Keyword Text View
None umbilical cord blood transplant View